{
  "slug": "apob",
  "name": "ApoB",
  "aliases": [
    "apolipoprotein B",
    "apo b test",
    "better than LDL"
  ],
  "family": "numbers",
  "heat": "high",
  "talk": "Lots of talk",
  "mostDiscussed": true,
  "firstLine": "ApoB is a protein measured in blood to estimate the number of cholesterol-carrying particles relevant to cardiovascular risk.",
  "whyLine": "People usually want to understand why this lab number adds something to a familiar cholesterol panel. The useful discussion connects the result to their wider risk picture, rather than turning one target into a universal verdict.",
  "feelWords": [
    "apob",
    "cholesterol",
    "ldl",
    "heart",
    "statin",
    "particle number"
  ],
  "commonPicture": [
    {
      "lead": "Units matter",
      "why": "Most U.S. examples in these notes use mg/dL. [community]"
    },
    {
      "lead": "A lab flag differs from a treatment target",
      "why": "Reported laboratory cut-points around 90–130 mg/dL and lower targets around 60–80 mg/dL describe different contexts. [community]"
    },
    {
      "lead": "Follow-up is spaced out",
      "why": "Accounts describe repeat measurements over months or years, depending on what is being evaluated. [community]"
    }
  ],
  "watchFor": "A number is information. What to do with it belongs with a clinician.",
  "whatPeopleSay": [
    "**The job:** A clearer atherogenic-particle number than LDL-C alone. [community]",
    "**Why it’s loud:** Attia / Dayspring / r/PeterAttia / r/Cholesterol made ApoB the 2020s calling card. [community]",
    "**What it is in one line:** Apolipoprotein B — one ApoB per atherogenic particle (LDL, VLDL, etc.). [trial]",
    "**Why people prefer it to LDL-C:** Discordance — “LDL looks fine, ApoB is high” threads. [trial]",
    "**Guidelines vs Twitter:** Some lipid societies have moved toward ApoB; many primary-care panels still don’t include it by default. That’s why people have to ask. [trial]",
    "**Medicine options are clinical decisions:** discussions name statins, ezetimibe, PCSK9-inhibiting medicines and bempedoic acid; a clinician determines whether one is appropriate. [community]",
    "**Diet theater** (keto vs seed oils vs olive oil) is how this card turns into a camp. We don’t. [community]",
    "**Function / Superpower PDFs** dump ApoB in a 100-marker page. Bring it to a person who can read it. [community]",
    "**Sniderman / Dayspring teaching:** ApoB counts particles that can enter the artery wall. LDL-C is how much cholesterol those particles happen to be carrying. [trial]",
    "**Discordance studies:** a slice of people have “fine LDL, high ApoB” or the reverse. That’s why the ask exists. [trial]",
    "**2020s guideline creep:** some endocrine/lipid documents elevate ApoB; many US annual physicals still omit it. People have to request it. [trial]",
    "**Attia public targets** are aggressive compared with a standard lab flag. Copying a podcast target without risk context is how anxiety happens. [community]",
    "**Lp(a)** is mostly genetic and once-measured; ApoB is the one that can move with meds and, less so, with weight and diet. [trial]",
    "**CAC scan** is a different question (plaque already there). People mix the two. [community]"
  ],
  "howPeopleRunIt": [
    "**Write “ApoB + Lp(a)” on a note** before the physical. [community]",
    "**Fasting:** follow whatever the lab/clinician said; they don’t fight the form. [community]",
    "**Don’t shop a “natural ApoB protocol”** off a podcast comments section. [community]",
    "**If it’s high, they book the follow-up,** they don’t buy red yeast rice from an ad. [community]",
    "**Same lab if they can** so the assay isn’t a new variable every time. [community]",
    "**Bring the PDF to a lipid-aware clinician,** not a supplement Discord. [community]",
    "**If they change a medicine,** they re-check on the timeline the clinician set. [community]"
  ],
  "amountsPeopleUse": [
    "**Units:** **mg/dL** on most US slips. [community]",
    "**Different kinds of target:** Attia-related discussions often mention very low values in high-risk situations, while laboratories use other flagging thresholds. A personal target needs the individual's risk context. [community]",
    "**Repeat interval talk:** **months to a few years** once a plan exists — not a weekly fingerstick. [community]",
    "**Lab flags** vary; a common US report might flag around **90–130 mg/dL** depending on the lab — they read *their* slip. [community]",
    "**Podcast-aggressive talk** sometimes aims **<60–80 mg/dL** for high-risk stories. Not a self-assigned target from this page. [community]"
  ],
  "howPeopleKeepIt": [
    "**Small version:** Ask once. Write it down. [community]",
    "**First week:** Don’t order three companies to “compare truth.” [community]",
    "**Time / cost:** A lab add-on. [community]",
    "**They track:** The number over years, with a clinician. [community]",
    "**It fades when:** They refresh Reddit instead of booking the draw. [community]"
  ],
  "howItFeels": [
    "**Before the draw:** Over-research. [community]",
    "**A number in range:** Quiet. That’s allowed. [community]",
    "**A high number:** Anxiety, then a plan with a clinician — or a spiral. The spiral is the fail. [community]",
    "**Relief after a first “I finally asked.”** Then they have to live with a number. [community]"
  ],
  "howLongPeopleRunIt": [
    "**A lifetime number to know,** managed over years. [community]",
    "**Lp(a) is usually once** unless the assay was messy. [community]",
    "**Repeat testing** follows the treatment plan — often **6–12 weeks** after a med change, then longer intervals. [community]"
  ],
  "deepDive": [
    "**What the number is:** Apolipoprotein B is a protein carried on atherogenic lipoprotein particles, including low-density lipoprotein (LDL), very-low-density lipoprotein (VLDL) and their remnants. The blood result reports ApoB concentration, used as an indicator of the number of these particles; “particle count” is shorthand. LDL-C measures the cholesterol carried in LDL particles, so two people can have the same LDL-C with different particle numbers. When the two disagree (discordance studies), ApoB is the one those rooms trust more for risk talk. [trial]",
    "**Why you have to ask:** many US annual physicals still omit ApoB. 2020s lipid and endocrine documents have been creeping toward it; primary care has not all caught up. People write “ApoB + Lp(a)” on a note before the visit. Lipoprotein(a), abbreviated Lp(a), is a different measure whose level is largely genetically determined. People often discuss it as a one-time baseline test, with testing decisions left to the clinician. ApoB can change with treatment and lifestyle. [trial]",
    "**Targets are where podcasts get dangerous:** a standard lab flag might sit somewhere around 90–130 mg/dL depending on the lab — read *your* slip. Attia-public conversation often pushes much lower numbers for high-risk stories. Copying a podcast target without your own risk context is how people spiral or start internet protocols. A personal target needs the individual's wider risk assessment. [community]",
    "**What moves it:** clinician tools (statins, ezetimibe, PCSK9 inhibitors, bempedoic acid, and others) are the serious levers. Diet and weight changes can also be part of care, but an online diet debate or supplement list does not select the appropriate treatment for an individual. [trial]",
    "**How people run the logistics:** same lab if they can, follow the fasting instructions on the form, bring the PDF to a lipid-aware clinician, re-check on the timeline after a medicine change (often 6–12 weeks), then stretch the interval. A coronary artery calcium (CAC) scan asks a different question by detecting calcified coronary plaque; it does not replace interpretation of the blood result. [community]",
    "**Soft voices:** Attia, Thomas Dayspring, Sniderman lectures, r/Cholesterol. Their explanations can help someone prepare questions, but do not provide an individualized medication plan. [community]",
    "**How to ask without a speech:** “Please add ApoB and Lp(a) to this lipid panel.” If the office shrugs, they ask whether the lab can add it to the same draw. They do not need a podcast monologue in the waiting room. [community]",
    "**Reading the slip:** find the units (usually mg/dL in the US), the lab’s flag, and the date. Compare only to their own prior slip from a similar assay. A result inside a Function/Superpower-style 100-marker panel still needs its units, date and clinical context; a bundled report does not replace interpretation. [community]",
    "**What a clinical plan can include:** confirm the number, look at risk (age, blood pressure, smoking, diabetes, family history, maybe CAC), then decide whether a medicine is worth it. Diet and weight can be part of that plan. Comment-section “natural protocols” are how months disappear. [community]",
    "**Anxiety hygiene:** one useful explanation, such as a Dayspring lecture or lipid clinic discussion, can be more helpful than repeatedly refreshing ApoB posts. Retesting follows the clinical plan over weeks or longer, rather than hourly reassurance checking. [community]",
    "**Family history changes interpretation:** a parent with an early heart attack and a high ApoB result create a different discussion from a mildly high result in a low-risk 30-year-old. A clinician can assess that wider context. [community]"
  ],
  "watchForLong": [
    "**Starting or stopping medicine needs a clinical plan.** A community target or isolated result is not that plan. [community]",
    "**Family heart history + a high ApoB** is a clinician conversation. [community]",
    "**Don’t let a PDF replace a person.** [community]",
    "**Stopping a statin because a YouTube comment said so** is the failure mode. [community]"
  ],
  "related": [
    "lp-a",
    "function-superpower",
    "home-blood-pressure",
    "ferritin",
    "testosterone-labs",
    "dexa"
  ],
  "researchPointer": [],
  "playPointer": null,
  "forums": [
    "r/PeterAttia",
    "r/Cholesterol",
    "r/Function_Health"
  ],
  "sources": [
    "Attia: ApoB as the particle count that matters",
    "Community target talk <60 mg/dL; lower 20–30 in aggressive posts",
    "r/PeterAttia: ‘does ApoB really matter?’ is a standing thread",
    "r/PeterAttia ApoB vs LDL discordance talk",
    "ApoB as particle number in lipid literature"
  ],
  "disclaimer": "Community talk may be wrong. Not medical or health advice. No result or safety is promised.",
  "quickAnswerHistory": [
    {
      "field": "communityPicture",
      "rows": [
        "People discuss requesting it alongside a cholesterol panel, particularly when different cholesterol numbers seem to tell different stories. The notes follow those conversations through lab reports, podcast targets and clinician interpretation, without making a result into a self-treatment plan."
      ]
    },
    {
      "field": "firstLine",
      "rows": [
        "The blood number Attia’s people ask for instead of the regular cholesterol panel."
      ]
    },
    {
      "field": "whyLine",
      "rows": [
        "ApoB is a blood count of the particles that carry cholesterol. People ask for it when a basic cholesterol panel felt incomplete."
      ]
    },
    {
      "field": "commonPicture",
      "rows": [
        {
          "lead": "Ask for ApoB once with a lipid panel",
          "why": "The whole first move. [community]"
        },
        {
          "lead": "One number, then a clinician",
          "why": "Not a supplement target. [community]"
        },
        {
          "lead": "Pair with Lp(a) if they haven’t had it",
          "why": "Once-in-a-lifetime genetic cousin. [community]"
        },
        {
          "lead": "Repeat in months to years, not weekly",
          "why": "It’s a blood mark, not a Whoop score. [community]"
        },
        {
          "lead": "Units: mg/dL on most U.S. reports",
          "why": "This is the unit used in the lab examples. [community]"
        },
        {
          "lead": "Reported lab flags: around 90–130 mg/dL",
          "why": "The discussion describes different laboratory cut-points. [community]"
        },
        {
          "lead": "Lower podcast targets: below 60–80 mg/dL",
          "why": "A separate high-risk discussion in the notes; not the same category as a lab reference range. [community]"
        }
      ]
    },
    {
      "field": "whatPeopleSay",
      "rows": [
        "**Statins / ezetimibe / PCSK9 / bempedoic** are clinician tools. This card does not start them. [community]"
      ]
    },
    {
      "field": "amountsPeopleUse",
      "rows": [
        "**Forum targets people repeat:** Attia-shaped talk often pushes **very low** numbers for high-risk stories; population labs use higher cut-points. This page does not assign you one. [community]"
      ]
    },
    {
      "field": "deepDive",
      "rows": [
        "**What the number is:** Apolipoprotein B. There is one ApoB on each atherogenic particle (LDL, VLDL, remnants). Sniderman and Dayspring teaching — and a lot of r/PeterAttia — treat ApoB as a particle *count*, while LDL-C is how much cholesterol those particles happen to be carrying. When the two disagree (discordance studies), ApoB is the one those rooms trust more for risk talk. [trial]",
        "**Why you have to ask:** many US annual physicals still omit ApoB. 2020s lipid and endocrine documents have been creeping toward it; primary care has not all caught up. People write “ApoB + Lp(a)” on a note before the visit. Lp(a) is mostly genetic and usually once; ApoB can move with medicines and, less dramatically, with weight. [trial]",
        "**Targets are where podcasts get dangerous:** a standard lab flag might sit somewhere around 90–130 mg/dL depending on the lab — read *your* slip. Attia-public conversation often pushes much lower numbers for high-risk stories. Copying a podcast target without your own risk context is how people spiral or start internet protocols. This page does not assign you a number. [community]",
        "**What moves it:** clinician tools (statins, ezetimibe, PCSK9 inhibitors, bempedoic acid, and others) are the serious levers. Diet theater (keto vs seed-oil wars) is how this card becomes a camp; we don’t run that fight. Weight change can move it some. Supplements from comment sections are how money disappears. [trial]",
        "**How people run the logistics:** same lab if they can, follow the fasting instructions on the form, bring the PDF to a lipid-aware clinician, re-check on the timeline after a medicine change (often 6–12 weeks), then stretch the interval. CAC scans answer a different question (plaque already there). [community]",
        "**Function / Superpower / Superpower-shaped PDFs** will dump ApoB in a 100-marker wall. Circle the number and take it to a person. Don’t let a PDF replace a clinician. [community]",
        "**Soft voices:** Attia, Thomas Dayspring, Sniderman lectures, r/Cholesterol. Steal the *ask*, not a self-prescribed drug list. [community]",
        "**Reading the slip:** find the units (usually mg/dL in the US), the lab’s flag, and the date. Compare only to their own prior slip from a similar assay. A Function PDF and a Quest slip may not be the same story. [community]",
        "**What a plan can look like (clinician, not this page):** confirm the number, look at risk (age, blood pressure, smoking, diabetes, family history, maybe CAC), then decide whether a medicine is worth it. Diet and weight can be part of that plan. Comment-section “natural protocols” are how months disappear. [community]",
        "**Anxiety hygiene:** they are allowed one good explainer (Dayspring lecture, a lipid clinic visit) and then they stop refreshing ApoB Twitter. The number changes on a months-to-years clock, not an hourly one. [community]",
        "**Family history is the other half of the slip:** a parent with an early heart attack plus a high ApoB is a different conversation than a low-risk 30-year-old with a mildly high number. This page cannot triage that. A clinician can. [community]",
        "**CAC, Lp(a), blood pressure, and ApoB** are a set, not a single magic. See Home blood pressure and Lp(a). They do not need every scan on Tuesday. They need one clear next ask. [community]",
        "**Why LDL-C fooled a generation of annual physicals:** two people can have the same LDL-C with different particle counts. ApoB counts the particles that can park in an artery wall. That is the discordance story in one breath. It is why this ask exists. [trial]",
        "**After the number:** they book the follow-up before they open a supplement store. If a medicine starts, they re-check on the clinician’s clock. If the number is fine, they stop refreshing lipid Twitter. Both are adult outcomes. [community]",
        "**One sentence to take to the visit:** “I want ApoB because it counts atherogenic particles; LDL-C can miss discordance.” Then they stop talking and let the clinician work. [community]"
      ]
    },
    {
      "field": "watchForLong",
      "rows": [
        "**This card does not tell anyone to start or stop a medicine.** [community]"
      ]
    }
  ]
}
